BofA raised the firm’s price target on Carlyle (CG) to $50 from $46 and keeps an Underperform rating on the shares. Though the firm notes Carlyle reported “solid” Q1 financial results and increased its 2026 and 2027 EPS forecasts to $4.50 and $5.05, respectively, driven by higher quality management fees and capital market transaction fees, the firm maintains an Underperform rating due to rising challenges to private equity, the company’s biggest business, in the North American and Chinese institutional channels.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- Positive Outlook for Carlyle Group: Buy Rating Supported by Strong Q1 2025 Results and Growth Potential
- Carlyle price target raised to $45 from $43 at Keefe Bruyette
- Cautious Hold Rating for Carlyle Group Amid EPS Forecast Adjustment and P/E Ratio Increase
- Carlyle price target raised to $49 from $43 at Barclays
- Carlyle Group Reports Strong Q1 2025 Financial Results